These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37244354)

  • 1. Development of nucleic acid medicines based on chemical technology.
    Kawamoto Y; Wu Y; Takahashi Y; Takakura Y
    Adv Drug Deliv Rev; 2023 Aug; 199():114872. PubMed ID: 37244354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics.
    Menzi M; Lightfoot HL; Hall J
    Future Med Chem; 2015; 7(13):1733-49. PubMed ID: 26424049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of sugar-modified oligonucleotides for antisense therapeutics.
    Prakash TP
    Chem Biodivers; 2011 Sep; 8(9):1616-41. PubMed ID: 21922654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era.
    Borbone N; Piccialli I; Falanga AP; Piccialli V; Roviello GN; Oliviero G
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming Pharmaceutical Bottlenecks for Nucleic Acid Drug Development.
    Lu M; Xing H; Zheng A; Huang Y; Liang XJ
    Acc Chem Res; 2023 Feb; 56(3):224-236. PubMed ID: 36624086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides.
    Bege M; Borbás A
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 35893733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.
    Campbell MA; Wengel J
    Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Medicinal Chemistry of Therapeutic Oligonucleotides.
    Wan WB; Seth PP
    J Med Chem; 2016 Nov; 59(21):9645-9667. PubMed ID: 27434100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of oligonucleotide-based therapeutics: challenges and opportunities.
    Hammond SM; Aartsma-Rus A; Alves S; Borgos SE; Buijsen RAM; Collin RWJ; Covello G; Denti MA; Desviat LR; Echevarría L; Foged C; Gaina G; Garanto A; Goyenvalle AT; Guzowska M; Holodnuka I; Jones DR; Krause S; Lehto T; Montolio M; Van Roon-Mom W; Arechavala-Gomeza V
    EMBO Mol Med; 2021 Apr; 13(4):e13243. PubMed ID: 33821570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01.
    Ashizawa AT; Cortes J
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1107-20. PubMed ID: 25539721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemistry and biology of oligonucleotide conjugates.
    Juliano RL; Ming X; Nakagawa O
    Acc Chem Res; 2012 Jul; 45(7):1067-76. PubMed ID: 22353142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-based nucleic acid therapeutics with in vivo efficacy.
    Sufian MA; Ilies MA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1856. PubMed ID: 36180107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Backbone modifications in oligonucleotides and peptide nucleic acid systems.
    De Mesmaeker A; Altmann KH; Waldner A; Wendeborn S
    Curr Opin Struct Biol; 1995 Jun; 5(3):343-55. PubMed ID: 7583633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in therapeutic nucleic acids and their analytical methods.
    Talap J; Zhao J; Shen M; Song Z; Zhou H; Kang Y; Sun L; Yu L; Zeng S; Cai S
    J Pharm Biomed Anal; 2021 Nov; 206():114368. PubMed ID: 34571322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2'-Modified oligonucleotides for antisense therapeutics.
    Prakash TP; Bhat B
    Curr Top Med Chem; 2007; 7(7):641-9. PubMed ID: 17430205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotides Containing C5-Propynyl Modified Arabinonucleic Acids: Synthesis, Biophysical and Antisense Properties.
    Pontarelli A; Wilds CJ
    Chembiochem; 2023 May; 24(9):e202300068. PubMed ID: 36857293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative developments and emerging technologies in RNA therapeutics.
    Halloy F; Biscans A; Bujold KE; Debacker A; Hill AC; Lacroix A; Luige O; Strömberg R; Sundstrom L; Vogel J; Ghidini A
    RNA Biol; 2022; 19(1):313-332. PubMed ID: 35188077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.